Free Trial

Zenas Biopharma (ZBIO) SEC Filings & 10K Form

Zenas Biopharma logo
$8.72 +0.22 (+2.59%)
As of 04/15/2025 04:00 PM Eastern

Recent Zenas Biopharma SEC Filings

DateFilerForm TypeView
04/01/2025
8:47 PM
Novo Holdings A/S (Filed by)
Zenas Biopharma (Subject)
Form SCHEDULE 13G
03/11/2025
5:51 AM
Zenas Biopharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/11/2025
5:15 AM
Zenas Biopharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/05/2025
6:17 AM
Zenas Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2024
3:30 PM
Oliveira Orlando (Reporting)
Zenas Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
3:31 PM
Fox Jennifer A. (Reporting)
Zenas Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2024
4:20 PM
MOULDER LEON O JR (Reporting)
Zenas Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
9:40 AM
FMR LLC (Filed by)
Zenas Biopharma (Subject)
Form SC 13G
11/12/2024
6:17 AM
Zenas Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/21/2024
3:18 PM
Xencor Inc (Filed by)
Zenas Biopharma (Subject)
Form SC 13G
09/25/2024
5:00 PM
NEA 18 Venture Growth Equity, L.P. (Filed by)
Zenas Biopharma (Subject)
Form SC 13G
09/23/2024
7:56 PM
SR ONE CAPITAL MANAGEMENT, LLC (Filed by)
Zenas Biopharma (Subject)
Form SC 13D
09/23/2024
7:11 PM
Longitude Capital Partners IV, LLC (Filed by)
Zenas Biopharma (Subject)
Form SC 13D
09/23/2024
3:16 PM
Enavate Sciences GP, LLC (Filed by)
Zenas Biopharma (Subject)
Form SC 13D
09/20/2024
5:34 PM
MOULDER LEON O JR (Reporting)
Zenas Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2024
4:16 PM
Wellington Biomedical Innovation Master Investors I L.P. (0001787092) (Reporting)
Zenas Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2024
3:15 PM
Enavate Sciences GP, LLC (Reporting)
Zebra Aggregator, LP (Reporting)
Zenas Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
7:54 PM
MOULDER LEON O JR (Reporting)
Zenas Biopharma (Issuer)
Form 4/A
09/17/2024
7:56 PM
Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
Harwin Peter Evan (Reporting)
Kiselak Tomas (Reporting)
Zenas Biopharma (Issuer)
Form 4/A
09/17/2024
6:52 PM
Lu Hongbo (Reporting)
Zenas Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
7:57 PM
ENRIGHT PATRICK G (Reporting)
Zenas Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
8:00 PM
Allen Patricia L (Reporting)
Zenas Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
8:01 PM
Lu Hongbo (Reporting)
Zenas Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
8:03 PM
Xiao Ting (Reporting)
Zenas Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
8:05 PM
ORLOFF JOHN J (Reporting)
Zenas Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
7:46 PM
MOULDER LEON O JR (Reporting)
Zenas Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
7:48 PM
Fox Jennifer A. (Reporting)
Zenas Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
7:50 PM
Farmer Joseph L (Reporting)
Zenas Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
7:51 PM
George Simeon (Reporting)
SR ONE CAPITAL MANAGEMENT, LLC (Reporting)
Zenas Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
7:52 PM
Oliveira Orlando (Reporting)
Zenas Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
7:54 PM
Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
Harwin Peter Evan (Reporting)
Kiselak Tomas (Reporting)
Zenas Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
7:54 PM
Nunn Jason Raleigh (Reporting)
Zenas Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
7:55 PM
Boylan James P (Reporting)
Zenas Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
3:40 PM
Zenas Biopharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
09/13/2024
3:22 PM
Zenas Biopharma (Filer)
Form 424B4
09/12/2024
11:15 PM
Zenas Biopharma (Filer)
Form EFFECT
09/12/2024
8:41 PM
Nunn Jason Raleigh (Reporting)
Zenas Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
8:41 PM
Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
Harwin Peter Evan (Reporting)
Kiselak Tomas (Reporting)
Zenas Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
8:42 PM
ENRIGHT PATRICK G (Reporting)
Zenas Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
8:43 PM
Lu Hongbo (Reporting)
Zenas Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
8:43 PM
ORLOFF JOHN J (Reporting)
Zenas Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
Is it CRAZY to still want reliable profits, despite this market? (Ad)

Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who – while everyone else watched their retirement get cut in half in 2008... Performed 103% better than the market. And the one who crushed the market by 4X during the COVID meltdown.

Click here to access this emergency tariff briefing now.
09/12/2024
8:44 PM
Xiao Ting (Reporting)
Zenas Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
8:45 PM
Wellington Biomedical Innovation Master Investors I L.P. (0001787092) (Reporting)
Zenas Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
8:33 PM
MOULDER LEON O JR (Reporting)
Zenas Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
8:34 PM
Fox Jennifer A. (Reporting)
Zenas Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
8:34 PM
Farmer Joseph L (Reporting)
Zenas Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
8:35 PM
Oliveira Orlando (Reporting)
Zenas Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
8:36 PM
Allen Patricia L (Reporting)
Zenas Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
8:37 PM
Boylan James P (Reporting)
Zenas Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
8:38 PM
Enavate Sciences GP, LLC (Reporting)
Zebra Aggregator, LP (Reporting)
Zenas Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
8:39 PM
George Simeon (Reporting)
SR ONE CAPITAL MANAGEMENT, LLC (Reporting)
Zenas Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
8:22 PM
Zenas Biopharma (Filer)
Form S-1MEF
09/12/2024
11:21 AM
Zenas Biopharma (Filer)
Form CERT
09/10/2024
2:47 PM
Zenas Biopharma (Filer)
Form 8-A12B
09/06/2024
5:10 AM
Zenas Biopharma (Filer)
Form S-1/A
08/22/2024
1:41 PM
Zenas Biopharma (Filer)
Form S-1
Registration statement under Securities Act of 1933  
05/14/2024
3:40 PM
Zenas Biopharma (Filer)
Form D
Notice of Exempt Offering of Securities 
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:ZBIO) was last updated on 4/16/2025 by MarketBeat.com Staff
From Our Partners